Why invest in Rezonence: An innovative product with market interest and momentum. Digital advertising is a rapidly growing sector.
Our mission is to help publishers increase revenues and advertisers truly engage with audiences.
We anticipate that in the future FreeWallÂ® could be the de-facto way for publishers to monetise their digital content.
Traditional publishers are facing an existential challenge:
2007 - US print revenue was $42.2bn and online revenue was $3.2bn
2013 - US print revenue was $17.3bn and online revenue was $3.4bn
This has resulted in an overall loss in revenue of $24.7bn in the USA alone
Our story so far:
- FreeWallÂ® is built and market ready
- Currently deployed on 10 publishers
- Capacity to deliver 50 million FreeWallsÂ® a month
- Six campaigns executed with the following clients:
- Previous clients we have worked with include:
Northern & Shell plc (OK & The Express)
BBC Top Gear
Johnston Press (The Scotsman, and several other regional press titles)
- Global patent filed and FreeWallÂ® is now a UK registered trademark (UK00003041724)
We are a current member of the BBC Worldwide Labs (BBCW) Accelerator Programme.
Investors pledging (in chronological order) the first £150,000 in respect of this Campaign will be allocated the company's SEIS entitlement. The remainder of investors will (if eligible) be entitled to claim under EIS. On pledges reaching £150,000 (the â€œSEIS Targetâ€), £150,000 will be released to the company and shares issued in respect of such sum. The remainder of the sums raised will be held by Crowd2Fund until such time as the company has spent 70% of the SEIS Target and the Campaign Target has been met.
Where will the funds go?
Back to the top
"Our mission is to help publishers increase revenues and advertisers truly engage with audiences."
Please see our risk section before making an investment decision.
Risk warningPast performance and forecasts are not reliable indicators of future results.
Your capital invested is not covered for compensation in the event of a loss by the FSCS.
Tax treatment will depend on the individual circumstances and may be subject to change.